Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes
暂无分享,去创建一个
T. Roskams | J. Wouters | O. Govaere | B. Topal | H. Vankelecom | A. Van den broeck | Wouter van Delm | L. Gremeaux | J. Allemeersch | W. van Delm
[1] P. Souček,et al. Differences in Transcript Levels of ABC Transporters Between Pancreatic Adenocarcinoma and Nonneoplastic Tissues , 2013, Pancreas.
[2] B. Topal,et al. Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine , 2012, BMC Cancer.
[3] J. Dou,et al. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. , 2012, Journal of cancer research and therapeutics.
[4] F. Wang,et al. Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells. , 2012, Biochemical pharmacology.
[5] T. Welling,et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. , 2011, Gastroenterology.
[6] M. Heslin,et al. Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma , 2011, British Journal of Cancer.
[7] Q. Lin,et al. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling , 2011, Proceedings of the National Academy of Sciences.
[8] Yves Moreau,et al. PINTA: a web server for network-based gene prioritization from expression data , 2011, Nucleic Acids Res..
[9] Meghana Kulkarni. Digital multiplexed gene expression analysis using the NanoString nCounter system. , 2011, Current protocols in molecular biology.
[10] A. Khanna,et al. Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells , 2010, Cellular & Molecular Biology Letters.
[11] F. Huang,et al. Characterization of a Cancer Stem Cell-Like Side Population Derived from Human Pancreatic Adenocarcinoma Cells , 2010, Tumori.
[12] Y. Miao,et al. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells. , 2010, Oncology reports.
[13] B. Topal,et al. Role of cancer stem cells in pancreatic ductal adenocarcinoma , 2009, Nature Reviews Clinical Oncology.
[14] T. Hibi,et al. Side population of pancreatic cancer cells predominates in TGF‐β‐mediated epithelial to mesenchymal transition and invasion , 2009, International journal of cancer.
[15] S. V. van Laere,et al. Pituitary Progenitor Cells Tracked Down by Side Population Dissection , 2009, Stem cells.
[16] C. Decaestecker,et al. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma , 2009, British Journal of Cancer.
[17] Tatsuya Ozawa,et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.
[18] B. Luo,et al. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. , 2009, Neoplasma.
[19] B. Alman,et al. Side population cells in human cancers. , 2008, Cancer letters.
[20] Lucio Pastore,et al. Klf5 is involved in self-renewal of mouse embryonic stem cells , 2008, Journal of Cell Science.
[21] Heshui Wu,et al. Persistence of side population cells with high drug efflux capacity in pancreatic cancer. , 2008, World journal of gastroenterology.
[22] C. Heeschen,et al. Metastatic cancer stem cells: A new target for anti-cancer therapy? , 2008, Cell cycle.
[23] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[24] Pedro Larrañaga,et al. A review of feature selection techniques in bioinformatics , 2007, Bioinform..
[25] R. Kist,et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool , 2007, Proceedings of the National Academy of Sciences.
[26] P. Dalerba,et al. Identification of pancreatic cancer stem cells. , 2006, Cancer research.
[27] Yusuke Nakamura,et al. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth , 2006, Cancer science.
[28] Maqc Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.
[29] Cor J. Veenman,et al. A protocol for building and evaluating predictors of disease state based on microarray data , 2005, Bioinform..
[30] H. Vankelecom,et al. The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. , 2005, Endocrinology.
[31] H. Kitagawa,et al. Fas ligand expression in human pancreatic cancer. , 2004, Oncology reports.
[32] M. Goodell,et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Ashley,et al. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma , 2004, Oncogene.
[34] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[35] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[36] H. Friess,et al. Expression of the Multidrug-Resistance 1 (MDR1) Gene and Prognosis in Human Pancreatic Cancer , 2000, Pancreas.
[37] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[38] H. Friess,et al. Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.